FIGO Staging for Ovarian Cancer (2014)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
The FIGO Staging for Ovarian Cancer (2014) calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include tumor location. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Stages ovarian, fallopian tube, and peritoneal cancer based on anatomical spread of disease
Clinical Indication
The FIGO Staging for Ovarian Cancer (2014) is indicated for bedside clinical practice to support Stages ovarian, fallopian tube, and peritoneal cancer based on anatomical spread of disease. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.
Limitations & Contraindications
Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.
Clinical Pearls & Action Plan
Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.
Based on anatomical spread: Stage I (confined to ovaries/tubes), Stage II (pelvic extension), Stage III (peritoneal/nodal spread), Stage IV (distant metastases)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tumor_location | string | Yes | Location and extent of primary tumor |
Evidence-Based References (EBM)
- Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014 Jan;124(1):1-5.
- Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014 Jun;133(3):401-4.
- Berek JS, Kehoe ST, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78.